News & Updates

Ozoralizumab, when used in combination with methotrexate (MTX), appears to yield significant reductions in the signs and symptoms of rheumatoid arthritis (RA) while having an acceptable tolerability, according to data from a double-blind, parallel-group, placebo-controlled phase II/III trial.

Breast cancer patients with urogenital atrophy may benefit from intravaginal laser therapy and hyaluronic acid suppositories, with a recent study showing that both help resolve related symptoms equally.

Treatment with fenfluramine produces sustained reductions in drop seizure frequency, especially generalized tonic-clonic seizures, in patients with Lennox-Gastaut syndrome (LGS), according to the results of an open-label extension trial.

Rivaroxaban reduces radial artery occlusion rate, without significantly increasing bleeds, in patients undergoing transradial coronary procedures in the RIVARAD study.

Treatment with the combination of pitavastatin plus ezetimibe effectively lowers low-density lipoprotein cholesterol (LDL-C) levels by more than 50 percent, with a safety profile comparable to that of pitavastatin monotherapy, according to the results of a phase III study.

Starting alirocumab early in the hospital prior to undergoing percutaneous coronary intervention (PCI) reduces LDL-cholesterol (LDL-C) in STEMI* patients already on high-statin therapy.

Preoperative administration of gabapentin helps reduce intraoperative pain in women undergoing second-trimester surgical abortion, leading to improved satisfaction with pain management, as shown in a randomized, controlled, double-blind trial.